Investigation of the dopamine system in frontotemporal dementia.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Tolcapone (Primary)
- Indications Dementia
- Focus Therapeutic Use
- 14 Jun 2016 Planned End Date changed from 1 Oct 2014 to 1 Oct 2016.
- 14 Jun 2016 Status changed from completed to active, no longer recruiting.
- 08 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.